Articles

fibrin, MSCs, stem cells, heart failure, Antoni Bayes-Genis, umbilical cord

To date, the only definitive treatment for heart failure – an organ transplant – is hampered by both the limited number of organ donors and the potential for the patient’s body to reject the new...

Philips, Lumify, app-based ultrasound, transducer

Philips announced the introduction of Lumify, its first app-based ultrasound solution that will extend the reach of ultrasound applications across the health continuum using mobile...

defibrillators, older heart patients, Duke Medicine study, Tracy Wang

Heart attack patients age 65 and older who have reduced heart function might still benefit from implanted defibrillators, according to a Duke Medicine study published in the Journal of the...

Medtronic, CoreValve Evolut R, FDA approval, TAVR, recapturable

Medtronic plc announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the recapturable, self-expanding CoreValve Evolut R System. The first-and-only recapturable and...

cangrelor, Kangreal, FDA approval, The Medicines Company, antiplatelet agent

The Medicines Company announced the approval of cangrelor (Kengreal) by the U.S. Food and Drug Administration (FDA) as an adjunctive therapy to percutaneous coronary...

Edwards, Sapien 3, FDA approval, transcatheter heart valve

Edwards Lifesciences Corp. announced U.S. Food and Drug Administration (FDA) approval of the Edwards Sapien 3 valve with the Commander Delivery System for the treatment of high-risk patients...

STEMI, ultrasound to treat heart attacks, ultrasound to treat STEMI

Breakthrough Research Demonstrates Contrast Ultrasound Can be Used as Heart Attack Treatment 

Toshiba, myocardial perfusion, CT perfusion

Cardiac computed tomography angiography (CCTA) is known to have excellent anatomical imaging, but has lacked the ability for functional assessments, requiring chest pain patients with intermediate...

Simbionix, 3D Systems, echo simulator

More than 50 companies and organizations will display their latest products and services at the American Society of Echocardiography’s (ASE) 26th Annual Scientific Sessions, June 12-16 at in...

Brilinta, Ticagrelor, PEGASUS TIMI-54, ACC, results

AstraZeneca announced full results from the PEGASUS-TIMI 54 study, a large-scale outcomes trial investigating Brilinta (ticagrelor) tablets plus low dose aspirin, at the American College of...